dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2021-06-25T11:06:43Z
dc.date.accessioned2022-12-19T22:37:11Z
dc.date.available2021-06-25T11:06:43Z
dc.date.available2022-12-19T22:37:11Z
dc.date.created2021-06-25T11:06:43Z
dc.date.issued2020-01-01
dc.identifierCritical Reviews in Analytical Chemistry.
dc.identifier1547-6510
dc.identifier1040-8347
dc.identifierhttp://hdl.handle.net/11449/208122
dc.identifier10.1080/10408347.2020.1839737
dc.identifier2-s2.0-85095726455
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5388719
dc.description.abstractThe drug rapamycin is a potent inhibitor of the mTOR complex, acting directly in the signaling cascade of this protein complex; interrupting cell proliferation, in addition to being an extremely efficient immunosuppressant. Currently this drug is being used in several types of cancer. Rapamycin has been a target of great interest within nanomedicine involving nanostructured systems for drug delivery aiming to increase the bioactivity and bioavailability of this drug. In addition, there is a constant search for analytical methods to identify and quantify this drug. Numerous high-performance liquid chromatography analytical techniques, mass spectrometry and immunoassay techniques have been employed efficiently in an attempt to develop increasingly sensitive analytical methods. Thus, this review sought to bring together current and relevant scientific works involving rapamycin and; besides analytical methods more used for quantification of this molecule.
dc.languageeng
dc.relationCritical Reviews in Analytical Chemistry
dc.sourceScopus
dc.subjectanalytical methods
dc.subjectdrug delivery
dc.subjectRapamycin
dc.titleBioproperties, Nanostructured System and Analytical and Bioanalytical Methods for Determination of Rapamycin: A Review
dc.typeOtros


Este ítem pertenece a la siguiente institución